| pubmed-article:6157332 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C0016215 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C0011315 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C0042769 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C0020960 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:6157332 | lifeskim:mentions | umls-concept:C1627358 | lld:lifeskim |
| pubmed-article:6157332 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6157332 | pubmed:dateCreated | 1980-10-24 | lld:pubmed |
| pubmed-article:6157332 | pubmed:abstractText | Enhanced dengue 2 virus (D2V) infection in suspension cultures of human peripheral blood mononuclear phagocytes (PBL) produced by subneutralizing concentrations of dengue antisera has been described previously. In this study, the enhancement phenomenon was found to be a general property of representative flavivirus antisera. All except one of 24 antisera, which had been raised by 1-3 injections of flaviviruses in rabbits, enhanced the growth of dengue 2 virus in human PBL. Flavivirus antisera showing the greatest level of cross-reactivity against a battery of 42 flavivirus antigens in the hemagglutination-inhibition test were most potent in enhancing dengue replication in PBL cultures. Cross-neutralizing reactivity did not relate to enhanced D2V infection. However nearly one-half of studied flavivirus antisera neutralized D2V at dilutions of 1:10 or 1:20. Heterotypic D2V neutralizing antibody could serve as a "brake" on infection enhancement in vivo. Observations should be made in the field to look for possible enhancement of dengue infection in heterotypic flavivirus immunes. | lld:pubmed |
| pubmed-article:6157332 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6157332 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6157332 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6157332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6157332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6157332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6157332 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6157332 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:6157332 | pubmed:issn | 0002-9637 | lld:pubmed |
| pubmed-article:6157332 | pubmed:author | pubmed-author:PorterfieldJ... | lld:pubmed |
| pubmed-article:6157332 | pubmed:author | pubmed-author:HalsteadS BSB | lld:pubmed |
| pubmed-article:6157332 | pubmed:author | pubmed-author:O'RourkeE JEJ | lld:pubmed |
| pubmed-article:6157332 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6157332 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:6157332 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6157332 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6157332 | pubmed:pagination | 638-42 | lld:pubmed |
| pubmed-article:6157332 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:meshHeading | pubmed-meshheading:6157332-... | lld:pubmed |
| pubmed-article:6157332 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:6157332 | pubmed:articleTitle | Enhancement of dengue virus infection in monocytes by flavivirus antisera. | lld:pubmed |
| pubmed-article:6157332 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6157332 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6157332 | lld:pubmed |
